indinavir-sulfate and Jaundice

indinavir-sulfate has been researched along with Jaundice* in 1 studies

Other Studies

1 other study(ies) available for indinavir-sulfate and Jaundice

Article	Year
[Jaundice with free bilirubin following preventive anti-retroviral therapy after sexual aggression]. Presse medicale (Paris, France : 1983), 1999, Jan-09, Volume: 28, Issue:1 Interest has recently focused on anti-HIV prophylaxis in case of sexual exposure. A circular from the French Ministry of Health (DGS/DH n(o) 97/560, 12 August 1997) envisages such treatment in certain risk situations such as sexual aggression. The toxic risk of prescribing a tritherapy or a bitherapy, even for a short period of a few weeks must be considered.. A 20-year-old rape victim with an uneventful medical history was given a prophylactic regimen including zidovudine, laminovudine and indinavir. Three months later, she developed free-bilirubin jaundice with biological signs of hemolysis.. We draw attention to the risk of severe adverse effects of short-duration anti-HIV prophylaxis in apparently healthy subjects. The protocol must included careful patient information and rigorous surveillance. Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Bilirubin; Female; HIV Infections; Humans; Indinavir; Jaundice; Rape; Retroviridae Infections; Zidovudine	1999

Article

Year

[Jaundice with free bilirubin following preventive anti-retroviral therapy after sexual aggression].

Presse medicale (Paris, France : 1983), 1999, Jan-09, Volume: 28, Issue:1

Interest has recently focused on anti-HIV prophylaxis in case of sexual exposure. A circular from the French Ministry of Health (DGS/DH n(o) 97/560, 12 August 1997) envisages such treatment in certain risk situations such as sexual aggression. The toxic risk of prescribing a tritherapy or a bitherapy, even for a short period of a few weeks must be considered.. A 20-year-old rape victim with an uneventful medical history was given a prophylactic regimen including zidovudine, laminovudine and indinavir. Three months later, she developed free-bilirubin jaundice with biological signs of hemolysis.. We draw attention to the risk of severe adverse effects of short-duration anti-HIV prophylaxis in apparently healthy subjects. The protocol must included careful patient information and rigorous surveillance.

Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Bilirubin; Female; HIV Infections; Humans; Indinavir; Jaundice; Rape; Retroviridae Infections; Zidovudine

1999